Background Antiplatelet agents are recommended for people with myocardial infarction and
acute coronary syndromes, transient ischaemic attack or stroke, and for those in whom …

Patients undergoing early surgery after coronary stent implantation are at increased risk for
mortality from ischemic and hemorrhagic complications. The optimal antiplatelet strategy in …

Importance Percutaneous coronary intervention (PCI) with stents is currently the most
commonly performed coronary revascularization procedure; hence, optimizing post-PCI …

About 5% of patients undergoing coronary stenting need to undergo surgery within the next
year. The risk of perioperative cardiac ischemic events, particularly stent thrombosis (ST), is …

Major perioperative cardiac events are estimated to complicate between 1.4% and 3.9% of
surgeries. Because most surgeries are elective, there is the opportunity to implement …

Background: Recent coronary stent placement and noncardiac surgery contribute to the risk
of adverse cardiac events, but the relative contributions of these two factors have not been …

Dokumenty przygotowane przez CPG nie zdejmują jednak w jakikolwiek sposób z
pracowników opieki zdrowotnej indywidualnej odpowiedzialności za podejmowanie …

Antiplatelet drugs are prescribed to prevent arterial thrombosis and especially the
recurrence of thrombotic events. The four main oral antiplatelets have two distinct …

Background—Epidemiology and consequences of surgery in patients with coronary stents
are not clearly defined, as well as the impact of different stent types in relationship with …

BACKGROUND: In November 2007, national guidelines were released recommending
delay of elective noncardiac surgery after cardiac revascularization with drug eluting stents …